Inicio・Lista de Acciones・Vaxart Inc

Vaxart Inc

Abierto

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

Máximo

Métricas clave
By Trading Economics
Ingresos	-19M -13M
Ventas	-12M 27M
P/B Media del Sector	2.5 47.946
BPA	-0.06
Margen de beneficios	-49.638
Empleados	65
EBITDA	-19M -12M

Dividendos
By Acuity
Próximas Ganancias	12 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-39M 104M
Apertura anterior	0
Cierre anterior	0

Vaxart Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 oct 2026, 23:55 UTC

Dexcom Inc's shares have declined in after-market trading, settling lower after an early high and remaining below their 20-day moving average.

7 oct 2026, 23:55 UTC

News

Aptiv PLC shares traded modestly lower in after-hours action following UBS's Buy rating and a lowered price target of $57.

7 oct 2026, 23:55 UTC

StoneX Group Inc's shares are trading modestly higher in after-market hours, despite a decline during the regular session and remaining below its 20-day moving average.

7 oct 2026, 23:55 UTC

Krispy Kreme Inc. is up in after-market trading, reaching a peak return after gaining ground since Wednesday's close, despite being 2.12% below its 20-day moving average.

7 oct 2026, 23:55 UTC

In after-market trading, Dycom Industries Inc is roughly flat since Wednesday's close, reflecting routine market behavior and remaining near the middle of its one-month range.

7 oct 2026, 23:55 UTC

Geo Group Inc is trading modestly lower in after-market hours, remaining below its 20-day moving average and near the lower end of its one-month range.

7 oct 2026, 23:51 UTC

ETF Constituents

The fund advanced in after-market trading, driven by significant gains in AXTI, AEHR, LITE, SMTC, and TSEM, and is above its 20-day moving average.

7 oct 2026, 23:51 UTC

Preferred Bank is experiencing a notable decline in after-market trading, with shares significantly below their 20-day moving average following Wednesday's close.

7 oct 2026, 23:51 UTC

Mueller Industries Inc. is trading lower in after-market hours, continuing its decline and remaining near the lower end of its one-month range.

7 oct 2026, 23:51 UTC

CVS Health Corp is trading modestly higher in after-market hours, with a cumulative return of 0.61% following Wednesday's close.

7 oct 2026, 23:51 UTC

Innoviva Inc has advanced in after-market trading, gaining ground since Wednesday's close and remaining above its 20-day moving average.

7 oct 2026, 23:51 UTC

O'Reilly Automotive Inc. is trading modestly higher in after-market hours, supported by significant gains in the automotive retail sector.

7 oct 2026, 23:51 UTC

Ginkgo Bioworks Holdings Inc is trading lower in after-market hours, marking its third consecutive session of declines following a significant dip earlier in the day.

7 oct 2026, 23:51 UTC

Novavax Inc's shares are trading modestly lower in after-market hours, continuing a trend of three consecutive daily declines despite remaining above the 20-day moving average.

7 oct 2026, 23:51 UTC

News

Hilton Worldwide Holdings Inc is trading modestly lower in after-market hours, breaking a recent trend of higher daily closes amid broader market shifts.

7 oct 2026, 23:51 UTC

Martin Marietta Materials Inc is trading modestly lower in after-market hours, having reversed an initial rise and remaining below its 20-day moving average.

7 oct 2026, 23:51 UTC

Lowe's Companies Inc has advanced modestly in after-market trading, despite trading below its 20-day moving average and near the lower end of its one-month range.

7 oct 2026, 23:51 UTC

Correlated Moves

Brixmor Property Group Inc is trading higher in after-market hours, reflecting notable gains since Wednesday's close, amid rising shares of W.P. Carey Inc.

7 oct 2026, 23:51 UTC

UK Housing Market Weakens as RICS Reports House Price Balance Falls to -0.32%, Heightening Investor Concerns Amid Economic Pressures

7 oct 2026, 23:51 UTC

RBA Meeting Minutes Set for October 13, Amid Speculation of Interest Rate Hike and Mixed Economic Signals in Australia.

7 oct 2026, 23:51 UTC

Australia's NAB Business Confidence report set for October 13 amid cautious pre-release expectations due to declining consumer sentiment and rising operational costs.

7 oct 2026, 23:51 UTC

Japan's Machinery Orders Data Release on October 14, 2026, Expected to Influence Capital Spending Insights Amid Mixed Economic Sentiment.

7 oct 2026, 23:50 UTC

Coty Inc. has advanced in after-market trading, continuing its upward momentum with notable gains following six consecutive sessions of increases.

7 oct 2026, 23:50 UTC

Abbott Laboratories is trading slightly higher in after-market hours, following a modest earlier session increase, though it remains below its 20-day moving average.

7 oct 2026, 23:50 UTC

Maximus Inc is trading modestly higher in after-market hours, continuing an upward trend and reaching its highest cumulative return since Wednesday's close.

7 oct 2026, 23:50 UTC

Mastercard Inc shares are trading lower in after-market hours, diverging from a recent trend of higher daily closes.

7 oct 2026, 23:50 UTC

Old Dominion Freight Line Inc. traded modestly higher in after-market hours, despite settling slightly lower from Wednesday's close amid broader market declines.

7 oct 2026, 23:50 UTC

IES Holdings Inc. has advanced modestly in after-market trading, recovering from earlier lows but remains below its 20-day moving average.

7 oct 2026, 23:50 UTC

Fidelity National Information Services Inc saw a modest increase in after-market trading, recovering from earlier losses but remains below its 20-day moving average.

7 oct 2026, 23:50 UTC

HP Inc. is trading modestly higher in after-market hours, reaching its highest cumulative return since Wednesday's close, with steady gains throughout the session.

Comparación entre iguales

Cambio de precio

Vaxart Inc previsión

Consenso

By TipRanks

0 ratings

Comprar

Mantener

Vender

De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para Vaxart Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.